March 14, 2023 4:51 PM
DRDO-developed technology behind critical drug approved by DCGI for radiological and nuclear emergencies
The manufacturing and marketing licenses for the commercial use of Prussian blue insoluble formulations have been granted to Scott-Edil Pharmacia Limited, Himachal Pradesh and Skanttr Lifescience, Gujarat by Drugs Controller General of India. <br />''<br />''It is one of the critical medicines listed by the World Health Organisation for radiological and nuclear emergencies. Defence Ministry said, the drug will be available under the trade name of Pru-DecorpTM and PruDecorp-MG. <br...